- Home
- NATR vs SLP Comparison
NATR vs SLP Comparison
Compare NATR & SLP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NATR
- SLP
- Stock Information
- Founded
- NATR 1972
- SLP 1996
- Country
- NATR United States
- SLP United States
- Employees
- NATR N/A
- SLP N/A
- Industry
- NATR Biotechnology: Pharmaceutical Preparations
- SLP EDP Services
- Sector
- NATR Health Care
- SLP Technology
- Exchange
- NATR Nasdaq
- SLP Nasdaq
- Market Cap
- NATR 297.2M
- SLP 282.4M
- IPO Year
- NATR N/A
- SLP 1997
- Fundamental
- Price
- NATR $17.30
- SLP $13.31
- Analyst Decision
- NATR Strong Buy
- SLP Buy
- Analyst Count
- NATR 2
- SLP 7
- Target Price
- NATR $20.50
- SLP $29.50
- AVG Volume (30 Days)
- NATR 119.5K
- SLP 360.6K
- Earning Date
- NATR 11-06-2025
- SLP 10-22-2025
- Dividend Yield
- NATR N/A
- SLP N/A
- EPS Growth
- NATR N/A
- SLP N/A
- EPS
- NATR 0.75
- SLP N/A
- Revenue
- NATR $460,818,000.00
- SLP $80,383,000.00
- Revenue This Year
- NATR $4.88
- SLP $12.75
- Revenue Next Year
- NATR $2.66
- SLP $3.06
- P/E Ratio
- NATR $22.89
- SLP N/A
- Revenue Growth
- NATR 4.33
- SLP 20.01
- 52 Week Low
- NATR $11.01
- SLP $12.39
- 52 Week High
- NATR $18.06
- SLP $37.67
- Technical
- Relative Strength Index (RSI)
- NATR 61.82
- SLP 43.15
- Support Level
- NATR $16.13
- SLP $13.93
- Resistance Level
- NATR $17.64
- SLP $14.52
- Average True Range (ATR)
- NATR 0.51
- SLP 0.50
- MACD
- NATR 0.02
- SLP 0.10
- Stochastic Oscillator
- NATR 68.55
- SLP 11.86
About NATR Nature's Sunshine Products Inc.
Natures Sunshine Products Inc is a natural health and wellness company, predominantly engaged in the manufacturing and selling of nutritional and personal care products. It offers products related to Weight management, General health, Cardiovascular, Digestive, Immune, and Personal care. The company operates in four segments namely, Asia which is also its key revenue generating market, Europe, North America, Latin America, and Other.
About SLP Simulations Plus Inc.
Simulations Plus Inc is engaged in the software industry. It includes two segments. It develops and produces software for use in pharmaceutical research and education, and provides consulting and contract research services to the pharmaceutical industry. The company's operating segments include Software and services. The company offers software products for pharmaceutical research such as ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity). It generates maximum revenue from the software segment. Maximum revenue is earned from USA following EMEA and Asia Pacific.